Raiyan Zaman

Sources

Sources are listed once and connected to each accepted claim they support. Excerpts preserve the source language used in the review.

1. [1]

   Raiyan Zaman, Ph.D. - Faculty Profile - UT Southwestern

   16 source claims · Reviewed Sep 7, 2026

   Show supporting evidence

   Biographical context: A biomedical imaging researcher, she develops hybrid optical, photoacoustic, ultrasound, and radioluminescence systems to detect and characterize vulnerable coronary plaques.

   Biography Dr. Raiyan T. Zaman’s research focuses on the design and development of cutting-edge multi-mode hybrid imaging system to overcome the limitation of currently available clinical imaging systems. Her research goal is to detect thin-cap-fibro-theroma (TCFA) early, the underlying causes of coronary artery disease (CAD), one of the leading causes of morbidity in the USA and worldwide. She further investigates to characterize the TCFA by identifying disease compositions and their progression over time to unravel this complex human disease. By integrating optical, photoacoustic, ultrasound, and radioluminescence, Dr. Zaman focuses to get the precise location of TCFA and its compositions. Her work seeks to better understand the disease mechanisms and its progression. Dr. Zaman is dissecting the role of TCFA perturbations on vascular wall processes during atherosclerosis progression. She is also interested in novel molecular imaging methods to study this deadly disease in subcellular level to further investigate the pharmacokinetics of TCFA. Dr. Zaman’s research has been well-recognized by the scientific communities as evidence of 59 prestigious accolades including Rising Star Award from WMIC in 2020, Anne Klibanski Visiting Scholar Award from Massachusetts General Hospital in 2020, Science Council Best paper Awrad from AAPM in 2019, Women in Molecular Imaging Network Scholar Award from WMIC in 2018, and Henry Wagner Jr. MD Best Abstract Award from SNMMI in 2017. She holds 4 US patents (one commercialized and one underway). Dr. Zaman published 59 first author peer-reviewed manuscripts and conference papers, 2 application-notes, and 1 book chapter. She has been well-funded for her research including two T32 training grants from Cardiovascular Imaging and Radiation Biology at the Stanford University School of Medicine (2011-2013), American Heart Association Fellowship (2013-2015), and highly competitive NHLBI sponsored K99 (2015-2018). These grants were awarded during 1st submission by scoring top 1%. She was also awarded R56 (2020-2021) by NIH for high-priority and high-impact project based on highly meritorious application. Her current research is supported by NIH sponsored R00 (2019-2023). Dr. Zaman’s vision for future is to predict this disease years before its actual occurrence. This can ultimately change the future of how CAD is diagnosed and managed by providing real-time tracking of the dynamic pathobiological information on human CAD, atherosclerosis biology, and relations to clinical complications, including myocardial infarction and sudden cardiac death. Such information can have an important positive impact by preventing heart attacks and their debilitating aftermath, plus reducing the financial burden on individuals as well as society.

   Biographical context: Her longer-term aim is earlier prediction of coronary disease through real-time pathobiological information, including atherosclerosis mechanisms and links to myocardial infarction and sudden cardiac death.

   Biography Dr. Raiyan T. Zaman’s research focuses on the design and development of cutting-edge multi-mode hybrid imaging system to overcome the limitation of currently available clinical imaging systems. Her research goal is to detect thin-cap-fibro-theroma (TCFA) early, the underlying causes of coronary artery disease (CAD), one of the leading causes of morbidity in the USA and worldwide. She further investigates to characterize the TCFA by identifying disease compositions and their progression over time to unravel this complex human disease. By integrating optical, photoacoustic, ultrasound, and radioluminescence, Dr. Zaman focuses to get the precise location of TCFA and its compositions. Her work seeks to better understand the disease mechanisms and its progression. Dr. Zaman is dissecting the role of TCFA perturbations on vascular wall processes during atherosclerosis progression. She is also interested in novel molecular imaging methods to study this deadly disease in subcellular level to further investigate the pharmacokinetics of TCFA. Dr. Zaman’s research has been well-recognized by the scientific communities as evidence of 59 prestigious accolades including Rising Star Award from WMIC in 2020, Anne Klibanski Visiting Scholar Award from Massachusetts General Hospital in 2020, Science Council Best paper Awrad from AAPM in 2019, Women in Molecular Imaging Network Scholar Award from WMIC in 2018, and Henry Wagner Jr. MD Best Abstract Award from SNMMI in 2017. She holds 4 US patents (one commercialized and one underway). Dr. Zaman published 59 first author peer-reviewed manuscripts and conference papers, 2 application-notes, and 1 book chapter. She has been well-funded for her research including two T32 training grants from Cardiovascular Imaging and Radiation Biology at the Stanford University School of Medicine (2011-2013), American Heart Association Fellowship (2013-2015), and highly competitive NHLBI sponsored K99 (2015-2018). These grants were awarded during 1st submission by scoring top 1%. She was also awarded R56 (2020-2021) by NIH for high-priority and high-impact project based on highly meritorious application. Her current research is supported by NIH sponsored R00 (2019-2023). Dr. Zaman’s vision for future is to predict this disease years before its actual occurrence. This can ultimately change the future of how CAD is diagnosed and managed by providing real-time tracking of the dynamic pathobiological information on human CAD, atherosclerosis biology, and relations to clinical complications, including myocardial infarction and sudden cardiac death. Such information can have an important positive impact by preventing heart attacks and their debilitating aftermath, plus reducing the financial burden on individuals as well as society.

   Biographical context: Zaman's research focuses on multimode imaging of thin-cap fibroatheroma and the progression of coronary artery disease. She combines optical, photoacoustic, ultrasound, and radioluminescence methods to locate plaques and characterize their composition.

   Biography Dr. Raiyan T. Zaman’s research focuses on the design and development of cutting-edge multi-mode hybrid imaging system to overcome the limitation of currently available clinical imaging systems. Her research goal is to detect thin-cap-fibro-theroma (TCFA) early, the underlying causes of coronary artery disease (CAD), one of the leading causes of morbidity in the USA and worldwide. She further investigates to characterize the TCFA by identifying disease compositions and their progression over time to unravel this complex human disease. By integrating optical, photoacoustic, ultrasound, and radioluminescence, Dr. Zaman focuses to get the precise location of TCFA and its compositions. Her work seeks to better understand the disease mechanisms and its progression. Dr. Zaman is dissecting the role of TCFA perturbations on vascular wall processes during atherosclerosis progression. She is also interested in novel molecular imaging methods to study this deadly disease in subcellular level to further investigate the pharmacokinetics of TCFA. Dr. Zaman’s research has been well-recognized by the scientific communities as evidence of 59 prestigious accolades including Rising Star Award from WMIC in 2020, Anne Klibanski Visiting Scholar Award from Massachusetts General Hospital in 2020, Science Council Best paper Awrad from AAPM in 2019, Women in Molecular Imaging Network Scholar Award from WMIC in 2018, and Henry Wagner Jr. MD Best Abstract Award from SNMMI in 2017. She holds 4 US patents (one commercialized and one underway). Dr. Zaman published 59 first author peer-reviewed manuscripts and conference papers, 2 application-notes, and 1 book chapter. She has been well-funded for her research including two T32 training grants from Cardiovascular Imaging and Radiation Biology at the Stanford University School of Medicine (2011-2013), American Heart Association Fellowship (2013-2015), and highly competitive NHLBI sponsored K99 (2015-2018). These grants were awarded during 1st submission by scoring top 1%. She was also awarded R56 (2020-2021) by NIH for high-priority and high-impact project based on highly meritorious application. Her current research is supported by NIH sponsored R00 (2019-2023). Dr. Zaman’s vision for future is to predict this disease years before its actual occurrence. This can ultimately change the future of how CAD is diagnosed and managed by providing real-time tracking of the dynamic pathobiological information on human CAD, atherosclerosis biology, and relations to clinical complications, including myocardial infarction and sudden cardiac death. Such information can have an important positive impact by preventing heart attacks and their debilitating aftermath, plus reducing the financial burden on individuals as well as society.

   Graduate education: University of Texas-Austin (Engineering)

   Through 2006

   Education Undergraduate University of Texas-Austin (2000), Electrical Engineering Graduate School University of Texas-Austin (2006), Engineering Graduate School University of Texas-Austin (2011), Philosophy

   Graduate education: University of Texas-Austin (Philosophy)

   Through 2011

   Education Undergraduate University of Texas-Austin (2000), Electrical Engineering Graduate School University of Texas-Austin (2006), Engineering Graduate School University of Texas-Austin (2011), Philosophy

   Official headshot: Portrait

   <img src="https://profileplus.swmed.edu/facultydata/217358/images/Zaman.resize.jpg" class="card__image" itemprop="image" alt="Raiyan Zaman, Ph.D. " style="max-width:200px;" />

   Official profile: Official profile

   Biography Dr. Raiyan T. Zaman’s research focuses on the design and development of cutting-edge multi-mode hybrid imaging system to overcome the limitation of currently available clinical imaging systems. Her research goal is to detect thin-cap-fibro-theroma (TCFA) early, the underlying causes of coronary artery disease (CAD), one of the leading causes of morbidity in the USA and worldwide. She further investigates to characterize the TCFA by identifying disease compositions and their progression over time to unravel this complex human disease. By integrating optical, photoacoustic, ultrasound, and radioluminescence, Dr. Zaman focuses to get the precise location of TCFA and its compositions. Her work seeks to better understand the disease mechanisms and its progression. Dr. Zaman is dissecting the role of TCFA perturbations on vascular wall processes during atherosclerosis progression. She is also interested in novel molecular imaging methods to study this deadly disease in subcellular level to further investigate the pharmacokinetics of TCFA. Dr. Zaman’s research has been well-recognized by the scientific communities as evidence of 59 prestigious accolades including Rising Star Award from WMIC in 2020, Anne Klibanski Visiting Scholar Award from Massachusetts General Hospital in 2020, Science Council Best paper Awrad from AAPM in 2019, Women in Molecular Imaging Network Scholar Award from WMIC in 2018, and Henry Wagner Jr. MD Best Abstract Award from SNMMI in 2017. She holds 4 US patents (one commercialized and one underway). Dr. Zaman published 59 first author peer-reviewed manuscripts and conference papers, 2 application-notes, and 1 book chapter. She has been well-funded for her research including two T32 training grants from Cardiovascular Imaging and Radiation Biology at the Stanford University School of Medicine (2011-2013), American Heart Association Fellowship (2013-2015), and highly competitive NHLBI sponsored K99 (2015-2018). These grants were awarded during 1st submission by scoring top 1%. She was also awarded R56 (2020-2021) by NIH for high-priority and high-impact project based on highly meritorious application. Her current research is supported by NIH sponsored R00 (2019-2023). Dr. Zaman’s vision for future is to predict this disease years before its actual occurrence. This can ultimately change the future of how CAD is diagnosed and managed by providing real-time tracking of the dynamic pathobiological information on human CAD, atherosclerosis biology, and relations to clinical complications, including myocardial infarction and sudden cardiac death. Such information can have an important positive impact by preventing heart attacks and their debilitating aftermath, plus reducing the financial burden on individuals as well as society.

   Research interests: atherosclerosis

   Dr. Raiyan T. Zaman’s research focuses on the design and development of cutting-edge multi-mode hybrid imaging system to overcome the limitation of currently available clinical imaging systems. Her research goal is to detect thin-cap-fibro-theroma (TCFA) early, the underlying causes of coronary artery disease (CAD), one of the leading causes of morbidity in the USA and worldwide. She further investigates to characterize the TCFA by identifying disease compositions and their progression over time to unravel this complex human disease. By integrating optical, photoacoustic, ultrasound, and radioluminescence, Dr. Zaman focuses to get the precise location of TCFA and its compositions. Her work seeks to better understand the disease mechanisms and its progression. Dr. Zaman is dissecting the role of TCFA perturbations on vascular wall processes during atherosclerosis progression. She is also interested in novel molecular imaging methods to study this deadly disease in subcellular level to further investigate the pharmacokinetics of TCFA.

   Research interests: coronary artery disease

   Dr. Raiyan T. Zaman’s research focuses on the design and development of cutting-edge multi-mode hybrid imaging system to overcome the limitation of currently available clinical imaging systems. Her research goal is to detect thin-cap-fibro-theroma (TCFA) early, the underlying causes of coronary artery disease (CAD), one of the leading causes of morbidity in the USA and worldwide. She further investigates to characterize the TCFA by identifying disease compositions and their progression over time to unravel this complex human disease. By integrating optical, photoacoustic, ultrasound, and radioluminescence, Dr. Zaman focuses to get the precise location of TCFA and its compositions. Her work seeks to better understand the disease mechanisms and its progression. Dr. Zaman is dissecting the role of TCFA perturbations on vascular wall processes during atherosclerosis progression. She is also interested in novel molecular imaging methods to study this deadly disease in subcellular level to further investigate the pharmacokinetics of TCFA.

   Research interests: hybrid biomedical imaging

   Dr. Raiyan T. Zaman’s research focuses on the design and development of cutting-edge multi-mode hybrid imaging system to overcome the limitation of currently available clinical imaging systems. Her research goal is to detect thin-cap-fibro-theroma (TCFA) early, the underlying causes of coronary artery disease (CAD), one of the leading causes of morbidity in the USA and worldwide. She further investigates to characterize the TCFA by identifying disease compositions and their progression over time to unravel this complex human disease. By integrating optical, photoacoustic, ultrasound, and radioluminescence, Dr. Zaman focuses to get the precise location of TCFA and its compositions. Her work seeks to better understand the disease mechanisms and its progression. Dr. Zaman is dissecting the role of TCFA perturbations on vascular wall processes during atherosclerosis progression. She is also interested in novel molecular imaging methods to study this deadly disease in subcellular level to further investigate the pharmacokinetics of TCFA.

   Research interests: molecular imaging

   Dr. Raiyan T. Zaman’s research focuses on the design and development of cutting-edge multi-mode hybrid imaging system to overcome the limitation of currently available clinical imaging systems. Her research goal is to detect thin-cap-fibro-theroma (TCFA) early, the underlying causes of coronary artery disease (CAD), one of the leading causes of morbidity in the USA and worldwide. She further investigates to characterize the TCFA by identifying disease compositions and their progression over time to unravel this complex human disease. By integrating optical, photoacoustic, ultrasound, and radioluminescence, Dr. Zaman focuses to get the precise location of TCFA and its compositions. Her work seeks to better understand the disease mechanisms and its progression. Dr. Zaman is dissecting the role of TCFA perturbations on vascular wall processes during atherosclerosis progression. She is also interested in novel molecular imaging methods to study this deadly disease in subcellular level to further investigate the pharmacokinetics of TCFA.

   Research interests: photoacoustic imaging

   Dr. Raiyan T. Zaman’s research focuses on the design and development of cutting-edge multi-mode hybrid imaging system to overcome the limitation of currently available clinical imaging systems. Her research goal is to detect thin-cap-fibro-theroma (TCFA) early, the underlying causes of coronary artery disease (CAD), one of the leading causes of morbidity in the USA and worldwide. She further investigates to characterize the TCFA by identifying disease compositions and their progression over time to unravel this complex human disease. By integrating optical, photoacoustic, ultrasound, and radioluminescence, Dr. Zaman focuses to get the precise location of TCFA and its compositions. Her work seeks to better understand the disease mechanisms and its progression. Dr. Zaman is dissecting the role of TCFA perturbations on vascular wall processes during atherosclerosis progression. She is also interested in novel molecular imaging methods to study this deadly disease in subcellular level to further investigate the pharmacokinetics of TCFA.

   Research interests: radioluminescence imaging

   Dr. Raiyan T. Zaman’s research focuses on the design and development of cutting-edge multi-mode hybrid imaging system to overcome the limitation of currently available clinical imaging systems. Her research goal is to detect thin-cap-fibro-theroma (TCFA) early, the underlying causes of coronary artery disease (CAD), one of the leading causes of morbidity in the USA and worldwide. She further investigates to characterize the TCFA by identifying disease compositions and their progression over time to unravel this complex human disease. By integrating optical, photoacoustic, ultrasound, and radioluminescence, Dr. Zaman focuses to get the precise location of TCFA and its compositions. Her work seeks to better understand the disease mechanisms and its progression. Dr. Zaman is dissecting the role of TCFA perturbations on vascular wall processes during atherosclerosis progression. She is also interested in novel molecular imaging methods to study this deadly disease in subcellular level to further investigate the pharmacokinetics of TCFA.

   Research interests: thin-cap fibroatheroma

   Dr. Raiyan T. Zaman’s research focuses on the design and development of cutting-edge multi-mode hybrid imaging system to overcome the limitation of currently available clinical imaging systems. Her research goal is to detect thin-cap-fibro-theroma (TCFA) early, the underlying causes of coronary artery disease (CAD), one of the leading causes of morbidity in the USA and worldwide. She further investigates to characterize the TCFA by identifying disease compositions and their progression over time to unravel this complex human disease. By integrating optical, photoacoustic, ultrasound, and radioluminescence, Dr. Zaman focuses to get the precise location of TCFA and its compositions. Her work seeks to better understand the disease mechanisms and its progression. Dr. Zaman is dissecting the role of TCFA perturbations on vascular wall processes during atherosclerosis progression. She is also interested in novel molecular imaging methods to study this deadly disease in subcellular level to further investigate the pharmacokinetics of TCFA.

   Research interests: ultrasound imaging

   Dr. Raiyan T. Zaman’s research focuses on the design and development of cutting-edge multi-mode hybrid imaging system to overcome the limitation of currently available clinical imaging systems. Her research goal is to detect thin-cap-fibro-theroma (TCFA) early, the underlying causes of coronary artery disease (CAD), one of the leading causes of morbidity in the USA and worldwide. She further investigates to characterize the TCFA by identifying disease compositions and their progression over time to unravel this complex human disease. By integrating optical, photoacoustic, ultrasound, and radioluminescence, Dr. Zaman focuses to get the precise location of TCFA and its compositions. Her work seeks to better understand the disease mechanisms and its progression. Dr. Zaman is dissecting the role of TCFA perturbations on vascular wall processes during atherosclerosis progression. She is also interested in novel molecular imaging methods to study this deadly disease in subcellular level to further investigate the pharmacokinetics of TCFA.

   Undergraduate education: University of Texas-Austin (Electrical Engineering)

   Through 2000

   Education Undergraduate University of Texas-Austin (2000), Electrical Engineering Graduate School University of Texas-Austin (2006), Engineering Graduate School University of Texas-Austin (2011), Philosophy

2. [2]

   UT Southwestern Division of Cardiology faculty directory

   1 source claim · Reviewed Sep 7, 2026

   Show supporting evidence

   Professional role: Assistant Professor

   Raiyan Zaman, Ph.D. Assistant Professor Biomedical Engineering and Internal Medicine